Wyeth Estrogens GMP Surveillance Will Address Dissolution Issues
Executive Summary
Wyeth is initiating a testing program to address dissolution issues with conjugated estrogens used in the company's lower-dose Prempro hormone replacement therapy
You may also be interested in...
Manufacturing Potency Problems Drive Rise In Recalls During 2002
An increase in potency-related manufacturing problems contributed to a rise in recalls during 2002
Manufacturing Potency Problems Drive Rise In Recalls During 2002
An increase in potency-related manufacturing problems contributed to a rise in recalls during 2002
Wyeth Low-Dose Prempro Approval Offers Message To Offset Safety Issues
Wyeth's approval of lower-dose Prempro gives the company a positive marketing message to counter the safety concerns raised by the Women's Health Initiative hormone replacement therapy study findings